Bharti Jayshankar December 3, 2024: A study conducted by researchers at Johns Hopkins University revealed concerning links between levothyroxine—a commonly prescribed medication for.
Bharti Jayshankar November 30, 2024: A study done by the  University of Texas MD Anderson Cancer Center revealed that some breast cells in healthy.
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.
Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way.
A sedentary lifestyle of more than 10.6 hours a day increases heart disease by up to 60%, according to a study by Mass.
HQ Team November 19, 2024: Eli Lilly announced promising results from its Phase 2 clinical trial of muvalaplin, an oral medication designed to.
Measles cases worldwide have risen 20% year-on-year in 2023 to about 10.3 million due to inadequate access to vaccines, according to new estimates.
The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,.
HQ Team November 13, 2024: ALK-Abelló, the Danish pharma company has acquired exclusive rights to Neffy (epinephrine nasal spray) from ARS Pharmaceuticals for.
